Dr. Brock Woodis

Associate Professor
Pharmacy Practice
College of Pharmacy & Health Sciences
Clinical Pharmacist Practitioner
Ambulatory Care
College of Pharmacy & Health Sciences
Associated Faculty, Doctor of Physical Therapy Program
Physical Therapy
College of Pharmacy & Health Sciences
Office Address:
Duke University Medical Center


Dr. Woodis is a board-certified pharmacotherapy specialist (BCPS) as well as a board-certified ambulatory care pharmacist (BCACP) through the Board of Pharmacy Specialties. He is also board-certified in advanced diabetes management (BC-ADM) through the American Association of Diabetes Educators. He practices as a Clinical Pharmacist Practitioner, a recognized credential by both North Carolina Medical and Pharmacy Boards, at Duke Family Medicine (DFM) in Durham, North Carolina. In this role, he holds prescribing privileges through a collaborative practice agreement with his supervising physician. Dr. Woodis provides pharmacist-managed outpatient/ambulatory care pharmacotherapy services including diabetes mellitus, hypertension, and dyslipidemia at DFM. In addition to coordinating the Women’s Health elective and teaching in the Campbell University College of Pharmacy & Health Sciences Doctor of Pharmacy program, Dr. Woodis also provides several lectures to the Physician Assistant programs at both Campbell University and Duke University.

His research interests include:

  • Clinical pharmacist practitioner impact on diabetes mellitus outcomes
  • Clinical pharmacist practitioner impact on hepatitis B vaccination rates
  • Clinical pharmacist practitioner impact on vitamin d deficiency identification and treatment


  • Postgraduate - Year 2 Pharmacy Residency, Family Medicine/Pharmacotherapy, University of North Carolina Hospitals and Clinics, Chapel Hill, NC, 2007
  • Postgraduate - Year 1 Pharmacy Residency, Wake Forest University Baptist Medical Center, Winston-Salem, NC, 2006
  • Pharm.D., Auburn University, Auburn, AL, 2005
  • Bachelor of Science, Biology, University of Alabama at Birmingham, Birmingham, AL, 2001


  • North Carolina Association of Pharmacists
  • American-Society of Health - System Pharmacists
  • American Association of Colleges of Pharmacy


  • McLendon AN and Woodis CB. A review of osteoporosis management in younger, premenopausal women. [accepted for publication on October 24, 2013 and slated for publication in the January 2014 issue of Women’s Health].
  • McLendon AN, Spivey JR, Woodis CB. African mango (Irvingia gabonensis) extract for weight loss: A systematic review. Journal of Nutritional Therapeutics 2013, 2:53-58.
  • Woodis CB, Fuentes D, Sease L. De-escalation of antipsychotic medications in an elderly patient with alzheimer’s dementia residing in an assisted living facility. The Mental Health Clinician (MHC). 2012 November. Available at http://cpnp.org/resource/mhc/2012/11/de-escalation-antipsychotic-medications-elderly-patient-alzheimers-dementia. Accessed November 5, 2012.
  • Woodis CB, McLendon AN, Muzyk AJ. Testosterone supplementation for hypoactive sexual desire disorder (HSDD) in women. Pharmacotherapy 2012, 32:38–53.
  • Bates JB, Buie LW, Woodis CB. Management of menorrhagia associated with chemotherapy-induced thrombocytopenia in women with hematologic malignancy. Pharmacotherapy 2011, 31:1092–1110.
  • Patel M and Woodis CB. CPP opportunities for the new practitioner/a new practitioner’s experience in becoming a CPP. North Carolina Pharmacist Fall 2011, 91:21.
  • Woodis CB. OB-GYN Disorders and Women’s Health. Section editor and case writer. In: Ginsburg DB. ASHP’s PharmPrep: Interactive Case-based Board Review, 4th ed. Bethesda: American Society of Health-System Pharmacists, 2011. Online version: updated annually. www.pharmpreponline.com.
  • Woodis CB. New Practitioner Spotlight: C. Brock Woodis. North Carolina Pharmacist Fall 2010, 90:18.
  • Woodis CB. Hormone therapy for the management of menopausal symptoms: pharmacotherapy update. Journal of Pharmacy Practice 2010, 23:540-7.
  • Karwa R and Woodis CB. Midodrine and octreotide in the treatment of cirrhosis-related hemodynamic complications. Ann Pharmacother 2009, 43:692-699.
  • Woodis CB. Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis. Ann Pharmacother 2008, 42:1085-9.